# Nascent Biotech, Inc. (NBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 3 | $ -1.20M | $ -711.0K | $ 59.0K | $ -763.7K |
| 2023 | $ 0 | $ -2.26M | $ -1.32M | $ 125.0K | $ 30.4K |
| 2022 | $ 0 | $ -3.01M | $ -1.24M | $ 470.2K | $ -1.36M |
| 2021 | $ 2.08M | $ 379.6K | $ -32.6K | $ 165.4K | $ -448.0K |
| 2020 | $ 0 | $ -5.57M | $ -1.45M | $ 109.8K | $ -1.23M |
| 2019 | $ 0 | $ -1.69M | $ -616.4K | $ 0 | $ -952.5K |
| 2018 | $ 0 | $ -2.43M | $ -904.3K | $ 0 | $ -491.3K |
| 2017 | $ 0 | $ -2.54M | $ -1.77M | $ 0 | $ 646.7K |
| 2016 | $ 4.13M | $ 1.18M | $ 114.9K | $ 0 | $ 685.7K |
| 2015 | $ 0 | $ -6.09M | $ -1.65M | $ 0 | $ -852.2K |
| 2014 | $ 0 | $ -2.24M | $ -986.3K | $ 60.0K | $ -1.64M |
| 2013 | $ 0 | $ -2.20M | $ -421.0K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.08 |
| Liabilities / Eq | -1.24 |
| Current Ratio | 0.19 |

## Other views

- [Metrics](https://sponda.capital/en/NBIO.md)
- [Charts](https://sponda.capital/en/NBIO/charts.md)
- [Compare](https://sponda.capital/en/NBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.